𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Small-cell lung carcinoma: Inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody

✍ Scribed by Kaname Maruno; Sami I. Said


Book ID
118346395
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
334 KB
Volume
52
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibition of proliferation of small int
✍ Mark Kidd; Andrew V. Schally; Roswitha Pfragner; Maximillian V. Malfertheiner; I πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 507 KB

## Abstract ## BACKGROUND. Currently, no consistently effective therapy is available to inhibit cell proliferation or metastasis of neuroendocrine tumor (NET) disease. The effects of 4 novel peptides were analyzed: a targeted cytotoxic analog of luteinizing hormone‐releasing hormone (LH‐RH) analog

Synthesis of peptide and pseudopeptide a
✍ Olga NyΓ©ki; Attila Rill; IstvΓ‘n SchΕ‘n; Antal Orosz; JΓ‘nos Schrett; LΓ‘szlΓ³ Bartha πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 1 views

Small cell lung cancer (SCLC) cell lines produce and secrete various peptide hormones, e.g. bombesin (BN)/gastrin releasing peptide (GRP) like peptides that are proposed to function as their autocrine growth factors. To inhibit the proliferative effect of these hormones we have synthesized short cha